These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23357301)

  • 1. High plasma levels of soluble ST2 but not its ligand IL-33 is associated with severe forms of pediatric dengue.
    Guerrero CD; Arrieta AF; Ramirez ND; Rodríguez LS; Vega R; Bosch I; Rodríguez JA; Narváez CF; Salgado DM
    Cytokine; 2013 Mar; 61(3):766-71. PubMed ID: 23357301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of soluble ST2 in serum associated with severity of dengue due to tumour necrosis factor alpha stimulation.
    Houghton-Triviño N; Salgado DM; Rodríguez JA; Bosch I; Castellanos JE
    J Gen Virol; 2010 Mar; 91(Pt 3):697-706. PubMed ID: 19889931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced levels of interleukin 33 and increased levels of soluble ST2 in subjects with amyotrophic lateral sclerosis.
    Lin CY; Pfluger CM; Henderson RD; McCombe PA
    J Neuroimmunol; 2012 Aug; 249(1-2):93-5. PubMed ID: 22633272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble ST2 as a marker of disease activity in systemic juvenile idiopathic arthritis.
    Ishikawa S; Shimizu M; Ueno K; Sugimoto N; Yachie A
    Cytokine; 2013 May; 62(2):272-7. PubMed ID: 23561929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated levels of soluble ST2 protein in dengue virus infected patients.
    Becerra A; Warke RV; de Bosch N; Rothman AL; Bosch I
    Cytokine; 2008 Feb; 41(2):114-20. PubMed ID: 18226917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum level of IL-33 and sST2 in patients with ankylosing spondylitis: associated with disease activity and vascular endothelial growth factor.
    Li XL; Lin TT; Qi CY; Yuan L; Xia LP; Shen H; Lu J
    J Investig Med; 2013 Jun; 61(5):848-51. PubMed ID: 23552178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting value of serum soluble ST2 and interleukin-33 for risk stratification and prognosis in patients with acute myocardial infarction.
    Zhang K; Zhang XC; Mi YH; Liu J
    Chin Med J (Engl); 2013; 126(19):3628-31. PubMed ID: 24112154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of soluble ST2 and interleukin-33 in patients with dermatomyositis and polymyositis.
    Yuan L; Yao L; Zhao L; Xia L; Shen H; Lu J
    Clin Exp Rheumatol; 2013; 31(3):428-32. PubMed ID: 23485578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The levels of soluble ST2 in sera and bullous fluid from patients with bullous pemphigoid.
    Wakatabi K; Komine M; Meephansan J; Matsuyama Y; Tsuda H; Tominaga S; Ohtsuki M
    Eur J Dermatol; 2012; 22(3):333-6. PubMed ID: 22494834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal serum interleukin-33 and soluble ST2 across early pregnancy, and their association with miscarriage.
    Kaitu'u-Lino TJ; Tuohey L; Tong S
    J Reprod Immunol; 2012 Sep; 95(1-2):46-9. PubMed ID: 22841163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble ST2 levels are associated with bleeding in patients with severe Leptospirosis.
    Wagenaar JF; Gasem MH; Goris MG; Leeflang M; Hartskeerl RA; van der Poll T; van 't Veer C; van Gorp EC
    PLoS Negl Trop Dis; 2009 Jun; 3(6):e453. PubMed ID: 19488407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble ST2 and interleukin-33 levels in coronary artery disease: relation to disease activity and adverse outcome.
    Demyanets S; Speidl WS; Tentzeris I; Jarai R; Katsaros KM; Farhan S; Krychtiuk KA; Wonnerth A; Weiss TW; Huber K; Wojta J
    PLoS One; 2014; 9(4):e95055. PubMed ID: 24751794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of interleukin 33 and soluble ST2 serum levels in liver failure.
    Roth GA; Zimmermann M; Lubsczyk BA; Pilz J; Faybik P; Hetz H; Hacker S; Mangold A; Bacher A; Krenn CG; Ankersmit HJ
    J Surg Res; 2010 Oct; 163(2):e79-83. PubMed ID: 20638676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of alarmin IL-33 are unchanged in autism spectrum disorder: a preliminary study.
    Barbosa IG; Rodrigues DH; Rocha NP; Sousa LF; Vieira EL; Simões-E-Silva AC; Kummer A; Teixeira AL
    J Neuroimmunol; 2015 Jan; 278():69-72. PubMed ID: 25595254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal levels of soluble IL-33R ST2 and IL-16 in allergic rhinitis: inverse correlation trends with disease severity.
    Baumann R; Rabaszowski M; Stenin I; Tilgner L; Gaertner-Akerboom M; Scheckenbach K; Wiltfang J; Chaker A; Schipper J; Wagenmann M
    Clin Exp Allergy; 2013 Oct; 43(10):1134-43. PubMed ID: 24074331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of soluble urokinase plasminogen activator receptor, soluble ST2, and IL-33 in bronchopulmonary dysplasia.
    Tunc T; Cekmez F; Yildirim S; Bulut O; Ince Z; Saldir M; Aydemir G; Yaman H; Coban A
    Pediatr Res; 2014 Jun; 75(6):788-92. PubMed ID: 24603291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of IL-8, IFNγ, IL-10, and TGF β and their gene expression levels in severe and non-severe cases of dengue virus infection.
    Pandey N; Jain A; Garg RK; Kumar R; Agrawal OP; Lakshmana Rao PV
    Arch Virol; 2015 Jun; 160(6):1463-75. PubMed ID: 25860648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble ST2 plasma concentrations predict mortality in HBV-related acute-on-chronic liver failure.
    Lei Z; Mo Z; Zhu J; Pang X; Zheng X; Wu Z; Wang K; Li X; Xie D; Gao Z
    Mediators Inflamm; 2015; 2015():535938. PubMed ID: 25892854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of interleukin-33 and soluble ST2 in serum and their association with disease severity in patients with chronic kidney disease.
    Bao YS; Na SP; Zhang P; Jia XB; Liu RC; Yu CY; Mu SH; Xie RJ
    J Clin Immunol; 2012 Jun; 32(3):587-94. PubMed ID: 22203232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum level of interleukin-33 and soluble ST2 and their association with disease activity in patients with Behcet's disease.
    Kim DJ; Baek SY; Park MK; Park KS; Lee JH; Park SH; Kim HY; Kwok SK
    J Korean Med Sci; 2013 Aug; 28(8):1145-53. PubMed ID: 23960440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.